Metastatic, Androgen Independent Prostate Cancer
2 clinical trials · Condition
◉ Watch Metastatic, Androgen Independent Prostate Cancer
| Record | Firm | Date |
|---|---|---|
| The Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate Cancer (NCT00459186) | Dana-Farber Cancer Institute | 2005-11-01 |
| Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442) (NCT00849290) | Dendreon | 2004-04-01 |
Track Metastatic, Androgen Independent Prostate Cancer automatically
Every clearance here is in the API, with alerts when new ones post.